Skip to content

Michael Bloch

Partner

London

Bloch Michael
Michael Bloch

Partner

London

Michael has extensive experience in a wide range of corporate finance and equity capital markets transactions, including IPOs, public and private acquisitions and disposals and auction processes, and private equity transactions, frequently on a cross-border basis.

Michael has also spent seven months on secondment in the ECM business team at Credit Suisse, and has previously worked on secondment at ExxonMobil.

“Rising Star” IFLR1000 2019 (Equity Capital Markets)

“‘Very technically savvy,’ ‘easy to work with’ and ‘a good, safe pair of hands.’” Chambers UK 2020 (Equity Capital Markets)

"He is really impressive" Chambers UK 2021 (Capital Markets: Equity)

"He has good experience and he's a nice guy to deal with" Chambers UK 2021 (Capital Markets: Equity)

"Next Generation Partner" Legall 500 UK 2021 (Equity Capital Markets - Mid-High Cap)

Other noteworthy experience includes advising:

  • Kuwait Energy on its USD650m acquisition by United Energy Group by way of scheme of arrangement.
  • McCarthy & Stone on its GBP388m IPO on the premium main market of the London Stock Exchange (issuer's counsel)
  • Tullet Prebon on its reverse takeover acquisition of the global hybrid voice-broking and information business of ICAP plc.
  • Cobham on its GBP500m and GBP512m rights issues on the London Stock Exchange (issuer's counsel)
  • Equinity on its GBP317m IPO on the premium main market of the London Stock Exchange (underwriters counsel)
  • Circassia Pharmaceuticals ont its GBP580m IPO on the premium main market of the London Stock Exchange and GBP275m placing and open offer in connection with the acquisitions of Aerocrine and Prosonix (issuer's counsel).
  • Softcat on its GBP153m IPO on the premium main market of the London Stock Exchange (underwriter's counsel)
  • Spire Healthcare on its GBP842m IPO on the premium main market of the London Stock Exchange (underwriter's counsel)
  • Sensyne Health a digital healthcare company that develops regulated medical products and services using artificial intelligence, on its GBP225m IPO on the London Stock Exchange's AIM market.
  • Medopad on its Series A funding round to develop its healthcare technology data-capture platform.
 

新闻与透视

Publications: 23 MARCH 2020

新冠疫情下合同及交易的风险解析与应对

应对 新冠疫情已经成为全球企业的首要任务。在中国国内疫情有所缓解,但境外形势日趋严峻的时期,本所律师从合同履行、公司治理、并购、首次公开发行、融资等各个方面,结合中国客户的实际情况,为客户分析新冠疫情带来的问题和挑战。

阅读更多

办公室

London

Allen & Overy LLP
One Bishops Square
London
E1 6AD

查看办公室详情 →

执业资格

专业资质

Admitted as solicitor, England and Wales, 2006

学历

MA (Oxon), History, University of Oxford, 2002

Dip. Law, Nottingham Law School, 2003

LPC, Nottingham Law School, 2004

经验精选

市场赞誉